Skip to main content
. 2019 Sep 17;15(1):199–207. doi: 10.5114/wiitm.2019.87492

Table III.

Follow-up outcomes of patients in two groups

Parameter LESS-NU (n = 25) RL-NU (n = 17) P-value*
Follow-up, mean (SD) [months] 31.57 (8.195) 32.75 (10.506) 0.722
Follow-up persons, n 21 12  
Chemotherapy, n (%) 18 (90) 11 (91.67) 0.876
Tumor recurrence rate, n: 5 3  
 Bladder recurrence, n (%) 2 (9.52) 1 (8.33)  
 Pelvic metastasis, n (%) 2 (9.52) 1 (8.33)  
 Bone metastasis, n (%) 1 (4.76) 1 (8.33)